跳至主要内容
临床试验/NCT03645109
NCT03645109已完成不适用

Effect of Suplementation of 5,000 UI Vitamin D3 on the Glycemic Profile in Patients With Gestational Diabetes Mellitus of the Hospital Civil de Guadalajara Dr. Juan I. Menchaca

Eva Elizabet Camarena Pulido2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Changes in the parameters that make up the glycemic profile

研究概览

简要总结

Randomized double-blind placebo-controlled clinical trial. Consists of the administration of 5,000 IU of vitamin D3 vs Placebo in patients with gestational diabetes mellitus during eight weeks. The objective is to analyze the effects of the intervention on the biochemical parameters that are part of the glycemic profile (insuline, HBA1c, glucose)

详细描述

Two groups of patients diagnosed with gestational diabetes mellitus. Once the selection criteria are verified, they will be assigned randomly in one of the two arms,one of them will recive 5,000 IU of vitamin D and the other one placebo (talcum food grade). Baseline measurements of vitamin D, glucose,insulin, HBA1c, calcium, phosphorus. At the end of the eight weeks will be determined again the aforementioned biochemical parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

The capsules with vitamin D or placebo have the same organoleptic characteristics. The jars and envelopes that contain them are identical. The envelopes are identified by a code that only knows who will analyze the data

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with a single pregnancy.
  • Patients diagnosed with GDM, which were diagnosed by a glucose tolerance curve 100 grams of glucose, with two altered results from the following: fasting> 95 miligrams / deciliter, 1 hour> 180miligrams / deciliter, 2 hour> 155miligrams / deciliter, 3hous> 140 miligrams / deciliter.
  • Gestational age between 24 -30 weeks confirmed with ultrasound of the 1st or 2nd trimester
  • Age between 18 and 40 years.

排除标准

  • Patients with pre-existing diabetes mellitus
  • Patients with predictive factors for vitamin D hypovitaminosis such as: use of anticonvulsants, renal disease, glomerular filtration rate <60milliliters / minute, thyroid disease or any other pre-existing endocrinological disorders.
  • Hypercalciuria> 300 miligrams / day
  • Patients taking vitamin D supplementation during the 6 months prior to the study (does not include polyvitamins with lower vitamin D concentrations <500 IU)
  • Active and passive smoking patients.

结局指标

主要结局

Changes in the parameters that make up the glycemic profile

时间窗: Eight weeks

Glucose, HBA1c, insuline,

次要结局

  • Changes in calcium, phosphorus and vitamin D3(Eight weeks)

研究者

发起方
Eva Elizabet Camarena Pulido
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Eva Elizabet Camarena Pulido

Clinical professor

Hospital Civil Juan I. Menchaca

研究点 (2)

Loading locations...

相似试验